ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2005
The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Pharmaceutical brochures in Lebanon: do they meet WHO recommendations?BMC primary care · 2022Article
- Critical Evaluation of Drug Advertisements in a Medical College in Lalitpur, Nepal.Journal of multidisciplinary healthcare · 2020Article
- Are claims made in orthodontic journal advertisements evidence-supported?The Angle orthodontist · 2015Article
- A Critical Analysis of Claims and Their Authenticity in Indian Drug Promotional Advertisements.Advances in medicine · 2015Article
- Differences in the volume of pharmaceutical advertisements between print general medical journals.PloS one · 2014Article
- Analysis of written advertising material distributed through community pharmacies in Riyadh, Saudi Arabia.Pharmacy practice · 2013Article
- Evaluation of rationality of promotional drug literature using World Health Organization guidelines.Indian journal of pharmacology · 2010Article
- Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.BMC public health · 2010Article
- Explanatory model of prescribing behavior in prescription of statins in family practice.Wiener klinische Wochenschrift · 2010Article
- Information provided by generic and brand-name pharmaceutical manufacturers in response to a request.Pharmacy world & science : PWS · 2007Article
- Advertising in medical journals: should current practices change?PLoS medicine · 2006Article
- A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?BMC family practice · 2006Article
- Standards for pharmaceutical advertising in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005Article
- Critical review of drug promotional literature using the World Health Organization guidelines.Journal of research in pharmacy practiceArticle
- Evaluating the reliability and accuracy of the promotional brochures for the generic pharmaceutical companies in Iraq using World Health Organization guidelines.Journal of pharmacy & bioallied sciencesArticle
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe primary goal of pharmaceutical advertisements is to convince physicians to prescribe the manufacturer's product. We sought to determine what materials are cited in support of claims in pharmaceutical ads and medical research articles, and whether health care professionals seeking to verify the claims could obtain these references.
methodsWe reviewed 438 unique ads from the 1999 issues of 10 American medical journals, and a random sample of 400 references in medical research articles selected from the same journals. We classified references as journal article, data on file, meeting abstract or presentation, book or monograph, marketing report, prescribing information, government document or Internet site. We attempted to confirm or obtain each reference through library and Internet searches or by direct request from the manufacturer. The main outcome we sought to determine was the availability of the reference to a clinician. We also ascertained the source of funding for original research cited in the ads and the research articles.
resultsIn the 438 ads with medical claims, 126 contained no references and 312 contained 721 unique references. Of these ad references, 55% (396/721) cited journal articles and 19% (135/721) cited data on file. In contrast, in the sample of research article references, 88% (351/400) cited journal articles and 8% (33/400) cited books. Overall, 84% of the citations from the ads were available: 98% of journal articles, 86% of books, 71% of meeting abstracts or presentations and 20% of data-on-file references. In all, 99% of the sample of research article references were available. We determined that 58% of the original research cited in the pharmaceutical ads was sponsored by or had an author affiliated with the product's manufacturer, as compared with 8% of the articles cited in the research articles.
interpretationMany pharmaceutical ads contain no references for medical claims. Although references to journal articles were usually obtainable, other published sources were not as easily acquired. The majority of unpublished data-on-file references were not available, and the majority of original research cited to substantiate claims in the pharmaceutical ads was funded by or had authors affiliated with the product's manufacturer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.